Novaluron and indoxacarb induced methemoglobinemia – unveiling a rare poisoning
DOI:
https://doi.org/10.15584/ejcem.2024.2.17Keywords:
emergency department, indoxacarb, methemoglobinemia, novaluron, poisoningAbstract
Introduction and aim. In India, the utilization of agricultural pesticides for intentional self-poisoning is a prevalent method, and it is associated with substantially higher fatality rates compared to other self-poisoning approaches. Plethora, an agricultural insecticide containing novaluron (5.25%) and indoxacarb (4.5%), has recently been introduced and widely used in India and various other regions for its broad-spectrum lepidopteran control. While there have been documented cases of isolated self-poisoning involving indoxacarb, there is currently no literature reporting incidents of human poisoning specifically related to novaluron.
Description of the case. An 83-Year-old male was presented to the emergency department (ED) with a history of consumption of 50 mL of an insecticide suspension concentrate called ‘PLETHORA’ to commit suicide. He had one episode of vomiting and dizziness after the ingestion. There was associated cyanosis, and the patient was put on high-flow oxygen at 10 L/min through a face mask. The patient was diagnosed to have methemoglobinemia and was successfully treated with methylene blue and ascorbic acid. One hour post methylene blue injection showed a methemoglobin level of 1%, and the patient gradually improved. Patients presenting with novaluron and indoxacarb poisoning require supportive treatment as there is no specific antidote. There should be a high index of suspicion for methemoglobinemia in such patients, and timely management is necessary to prevent further complications. The patient was successfully managed and discharged after the 3rd day of admission.
Conclusion. The management of patients with novaluron and indoxacarb poisoning primarily involves supportive care, as there is currently no specific antidote available for these substances. Maintaining a high suspicion index for the development of methemoglobinemia and timely management of other complications is crucial for the best possible patient outcomes.
Downloads
References
Dawson AH, Eddleston M, Senarathna L, et al. Acute human lethal toxicity of agricultural pesticides: a prospective cohort study. PLoS Med. 2010;7(10):1000357. doi: 10.1371/journal.pmed.1000357
Bonvoisin T, Utyasheva L, Knipe D, Gunnell D, Eddleston M. Suicide by pesticide poisoning in India: a review of pesticide regulations and their impact on suicide trends. BMC Public Health. 2020;20(1):251. doi: 10.1186/s12889-020-8339-z
Ghosal A, Dolai AK, Chatterjee M. Plethora (Novaluron+ Indoxacarb) insecticide for the management of tomato fruit borer complex. J Appl. Nat Sci. 2016;8(2):919-922.
Prasanna L, Rao SM, Singh V, Kujur R, Gowrishankar. Indoxacarb poisoning: an unusual presentation as methemoglobinemia. Indian J Crit Care Med. 2008;12(4):198-200. doi: 10.4103/0972-5229.45082
Firoozabadi AS, Nasri-Nasrabadi Z, Marashi SM. Management of indoxacarb poisoning in a regional setting. Indian J Crit Care Med. 2016;20(10):627-628. doi: 10.4103/0972-5229.192067
Jacob J, CH KR, James J, Janardhanan N. Too Blue To Be True”: Indoxacarb Induced Methemoglobinemia-A Rare Case. Indian J Forensic Med Toxicol. 2021;15(4):1501-1507.
Hwang JM, Bae JW, Jung EJ, Lee WJ, Kwon WS. Novaluron Has Detrimental Effects on Sperm Functions. Int J Environ Res Public Health. 2021;19(1):61. doi: 10.3390/ijerph19010061
National Center for Biotechnology Information. PubChem Compound Summary for CID 93541, Novaluron. https://pubchem.ncbi.nlm.nih.gov/compound/Novaluron. Accessed August 15, 2023.
Shih PC, Tsai TH. Methemoglobinemia following ingestion of Indoxacarb: A case report. J Acute Med. 2011;1(2):55-57. doi: 10.1016/j.jacme.2011.10.005
Iolascon A, Bianchi P, Andolfo I, et al. Recommendations for diagnosis and treatment of methemoglobinemia. Am J Hematol. 2021;96(12):1666-1678. doi: 10.1002/ajh.26340
Rehman HU. Methemoglobinemia. West J Med. 2001;175(3):193-196. doi: 10.1136/ewjm.175.3.193
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
